Impact of statin treatment on non-invasive tests based predictions of fibrosis in a referral pathway for NAFLD
Objective In non-alcoholic fatty liver disease (NAFLD), fibrosis determines the risk of liver complications. Non-invasive tests (NITs) such as FIB-4, NAFLD Fibrosis Score (NFS) and Hepamet, have been proposed as a tool to triage NAFLD patients in primary care (PC). These NITs include AST±ALT in thei...
Saved in:
| Main Authors: | Juan G Abraldes, Mang Ma, Mustafa Al-Karaghouli, Sonia Fuentes, Tracy Davyduke |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2022-12-01
|
| Series: | BMJ Open Gastroenterology |
| Online Access: | https://bmjopengastro.bmj.com/content/9/1/e000798.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Statin therapy for NAFLD: Molecular underpinnings of myopathic consequences and treatment strategies
by: Pratiksha Nanepag, et al.
Published: (2025-06-01) -
Effects and mechanisms of liraglutide in ameliorating liver fibrosis in NAFLD mice
by: WANG Renjie, et al.
Published: (2025-04-01) -
The level of serum C-peptide signals fibrosis in obese patients with NAFLD
by: May Mohsen Fawzi, et al.
Published: (2025-07-01) -
Correlation between hs-CRP-triglyceride glucose index and NAFLD and liver fibrosis
by: Yuhui Zhou, et al.
Published: (2025-04-01) -
Elevated GGT to HDL ratio as a marker for the risk of NAFLD and liver fibrosis
by: Yanyan Xuan, et al.
Published: (2025-01-01)